Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving the way for future treatments.
Kronos mulls ‘strategic alternatives’ after axing cancer drug development
Kronos has downsized twice in the past year, firing 19% of its staff in November 2023 and then a further 21% in March 2024. Image